Bioxel Pharma Inc. Company Profile

10:01 EST 24th November 2014 | BioPortfolio

Bioxel is a biopharmaceutical company focused on the manufacture and distribution of taxane pharmaceutical ingredients including paclitaxel, docetaxel, 9-DHB and 10-DAB. The Corporation has rolled out an integrated taxane manufacturing chain that complies with the pharmaceutical industry's highest standards. Drawing on its high-efficiency processes and exclusive technologies, Bioxel guarantees that its customers are supplied with high-quality taxane products on a reliable and sustainable basis.

Location

3075 Chemin des Quatre-BourgeoisSuite 440
Sainte-Foy
Quebec
G1W 4Y5
Canada

Contact

Phone: (418) 654-9666
Fax: (418) 654-9655
Email: clients@bioxelpharma.com


News Articles [1396 Associated News Articles listed on BioPortfolio]

Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma

LONDON, August 6, 2014 /PRNewswire/ --read more

Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma

LONDON, July 23, 2014 /PRNewswire/ -- On Tuesday, July 22, 2014, the NASDAQ Composite ended at 4,456.02, up 0.71%, the Dow Jones Industrial Average finished the day 0.36% higher at 17,113.54, and ...

Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma

LONDON, August 6, 2014 /PRNewswire/ -- On Tuesday, August 5, 2014, the NASDAQ Composite ended at 4,352.84, down 0.71%, the Dow Jones Industrial Average declined 0.84%, to finish the day at 16,429....

Download: The future of Pharma

At DigiPharm 2013, we were joined by Professor Brian D. Smith, author of “The Future of Pharma” who gave an in-depth presentation on how pharma has evolved and where it is heading. What sc...

Technical Pulse on Pharma Stocks -- Research on Valeant Pharma Intl., Acura Pharma, Teva Pharma Industries, and Lannett

LONDON, June 11, 2014 /PRNewswire/ -- On Tuesday, June 10, 2014, the NASDAQ Composite ended at 4,338.00, up 0.04%, the Dow Jones Industrial Average finished the day 0.02% higher at 16,945.92, and ...

Omega Pharma rumored to be sought after by big pharma companies

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Inge...

Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma

LONDON, August 14, 2014 /PRNewswire/ --read more

Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics

LONDON, August 20, 2014 /PRNewswire/ --read more

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

Clinical Trials [42 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Development of a New Method for Analgesia

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Companies [643 Associated Companies listed on BioPortfolio]

Bioxel Pharma Inc.

Bioxel is a biopharmaceutical company focused on the manufacture and distribution of taxane pharmaceutical ingredients including paclitaxel, docetaxel, 9-DHB and 10-DAB. The Corporation has rolled out...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

More Information about "Bioxel Pharma Inc." on BioPortfolio

We have published hundreds of Bioxel Pharma Inc. news stories on BioPortfolio along with dozens of Bioxel Pharma Inc. Clinical Trials and PubMed Articles about Bioxel Pharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioxel Pharma Inc. Companies in our database. You can also find out about relevant Bioxel Pharma Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Prostate Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record